Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Finance Report
Month 11
Page 1 of 39 Finance, Performance & Workforce
Committee 21 March 2019
AGENDA ITEM 3.1
21 March 2019
Finance, Performance & Workforce Committee Report
FINANCE UPDATE – MONTH 11 OF 2018/19
Executive Lead: Director of Finance
Author: Deputy Director of Finance
Contact Details for further information: Mark Thomas 01443 443845 or
email [email protected]
Purpose of the Finance, Performance & Workforce Committee Report
The purpose of the attached report is to highlight the key messages in relation
to the Month 11 financial position.
Governance
Link to Health
Board Strategic Objective(s)
The Board’s overarching role is to ensure its Strategy
outlined within ‘Cwm Taf Cares’ 3 Year Integrated Medium Term Plan 2015-2018 and the related organisational
objectives, aligned with the Institute of Healthcare Improvement's (IHI) ‘Triple Aim’ are being progressed,
these in summary are; To improve quality, safety and patient experience.
To protect and improve population health. To ensure that the services provided are accessible
and sustainable into the future. To provide strong governance and assurance.
To ensure good value based care and treatment for
our patients in line with the resources made available to the Health Board.
The report aligns specifically with ensuring good value based care and treatment for our patients in line with the
resources made available to the Health Board.
Supporting
evidence
N/A.
Engagement – Who has been involved in this work?
The Month 11 position and forecast year end position for the Health Board has been shared with Welsh Government (WG) via our monthly Monitoring return
submissions.
Finance Report
Month 11
Page 2 of 39 Finance, Performance & Workforce
Committee 21 March 2019
Finance, Performance & Workforce Committee Resolution to:
APPROVE ENDORSE DISCUSS NOTE
Recommendation The Finance, Performance & Workforce Committee is
asked to: DISCUSS the contents of the Month 11 Finance
report for 2018/19.
Summarise the Impact of the Finance, Performance & Workforce Committee Report
Equality and Diversity N/A
Legal Implications No direct legal implications.
Population Health N/A.
Quality, Safety & Patient Experience
N/A
Resources The paper is directly relevant to the allocation
and utilisation of resources.
Risks and Assurance The key risks to the 2018/19 Financial Plan are
explained in the forecast section of the report.
Health and Care Standards
N/A
Workforce N/A
Freedom of information status
Open
Glossary of Terms
Acronym Meaning
A&C Administration & Clerical
AWCP All Wales Capital Programme
AME (WG) Annually Managed Expenditure
CHC Continuing Healthcare
COO Chief Operating Officer
CRES Cash Releasing Efficiency Savings
CRL Capital Resource Limit
FNC Funded Nursing Care
HCHS Healthcare & Hospital Services
IHI Institute of Healthcare Improvements
IMTP Integrated Medium Term Plan
I&E Income & Expenditure
LTA Long Term Agreement
M1 Month 1 (M2 Month 2 etc)
PCMH Primary Community & Mental Health
RGH Royal Glamorgan Hospital
PCH Prince Charles Hospital
PSPP Public Sector Payment Policy
WG Welsh Government
WHSSC Welsh Health Specialised Services Committee
YTD Year to Date
Finance Report
Month 11
Page 3 of 39 Finance, Performance & Workforce Committee
21 March 2019
FINANCE REPORT – MONTH 11 of 2018/19
1. SITUATION / PURPOSE OF REPORT
The purpose of this report is to highlight the key messages in relation to the current month, year to date and forecast year- end financial position of Cwm Taf University Health Board as at Month 11 (M11).
2. BACKGROUND / INTRODUCTION
This report should be read in the context of the University Health Board’s Integrated Medium Term Plan which is available on the website.
The Health Board’s original financial plan for 2018/19 was approved by the Board on 29 March 2018.
This plan assumed additional Welsh Government funding of £9.0m. Further to recent discussions with the Welsh Government this funding has now been revised downwards to £3.5m. A revised financial plan to accommodate this reduced level of funding
was agreed by the Board on 29 May 2018. The revised annual budget is circa £650m. This report reflects performance against the revised financial plan.
The Health Board’s Integrated Medium Term Plan (IMTP) for 2018/19 to 2020/21 was approved by the Welsh Government on
13 June 2018.
Finance Report
Month 11
Page 4 of 39 Finance, Performance & Workforce Committee
21 March 2019
Report Sections
The following sections are included in this report:
Section No. Section Page Number
Headline Messages
3.1 Headline Messages @ Month 11 5
Summary Analysis
3.2 Financial Performance and Key Targets 6
3.3 Revenue Performance by Expenditure Category 7
3.4 Revenue Performance by Division 12
3.5 Pay Expenditure 14
3.6 Non Pay Expenditure 22
3.7 Income 27
3.8 Savings Plan Performance 29
3.9 Non Delegated Budgets 32
3.10 Welsh Government Allocations 34
3.11 Performance against Capital Resource Limit 35
3.12 Public Sector Payment Performance 36
3.13 Balance Sheet 37
3.14 Cash Flow 38
Finance Report
Month 11
Page 5 of 39 Finance, Performance & Workforce Committee
21 March 2019
3. ASSESSMENT / GOVERNANCE AND RISK ISSUES
3.1 Headline Messages - Month 11
The M11 year to date income and expenditure position remains very close to budget and the M11 year end forecast remains a breakeven position (sections 3.2 to 3.4). This forecast includes provision for one off investment opportunities in 2018/19
of £4.3m and the Executive Team have earmarked this funding across a range of priority areas including:
- Referral to Treatment (RTT) and other backlogs - Equipment replacement
- Paediatrics, Obstetrics & Neonates (PON) and maternity support - Invest to Save schemes
We have reported a forecast break even position to WG at M11 together with a worse case of breakeven and a best case of
a £0.5m surplus.
The Health Board’s performance in meeting its ‘Prompt Payment’ target improved to 95.5% against a target of 95% during February and continues to remain on target for the year to date (see summary in section 3.2 and detail in section 3.12).
Capital expenditure to M11 is only £0.08m below the phased plan. The Capital Resource Limit currently stands at £27.0m
with expenditure to M11 of only £15.3m. Significant expenditure is planned for M12 in order to fully utilise the Capital Resource Limit. (see summary in section 3.2 and detail in section 3.11).
The M11 In month delegated overspend was £1.1m compared to an average overspend for the first 10 months of £1.0m.
The M11 YTD under spend of £0.03m continues to be made up of a significant delegated overspend (£10.9m), offset by an under spend on non-delegated budgets and reserves (£10.9m). See sections 3.3 and 3.9 for details.
Forecast savings have improved to £11.6m and this represents a £2.0m shortfall in savings against the £13.6m target. See
section 3.8 for details of performance on savings against plan.
The 2018/19 Financial Plan had a planned recurrent deficit going into 2019/20 of £4.8m.We are now forecasting a recurrent
underspend in 2018/19 of £4.4m which reduces the recurrent deficit going into next year to £0.4m. This is consistent with our IMTP submission on the 7th March. See Section 3.3 for details.
Finance Report
Month 11
Page 6 of 39 Finance, Performance & Workforce Committee
21 March 2019
3.2 Financial Position and Key Targets – Month 11
The Health Board has a statutory duty to achieve a break even position over a period of three financial years. This applies to both revenue and capital expenditure. Over the last two financial years, the Health Board has achieved a small
surplus of £42k and £14k for revenue and capital expenditure respectively. This means that the Health Board can overspend by £42k and £14k for revenue and capital expenditure respectively in 2018/19 and still meet its three year
statutory duty. The Health Board’s plan for 2018/19 is to break-even on both measures. The Health Board also has an administrative duty to pay a minimum of 95% of all non-NHS invoices within 30 days.
The table below details the Health Board’s 2018/19 current and forecast performance against these key financial targets:
Target Unit Current Month
Year to Date
Trend Forecast Year End
Revenue To ensure that the Health Board’s revenue expenditure does
not exceed the aggregate of it’s funding in each financial
year. Measured by variance against plan to break even.
£’000
+Adverse
()Favourable
(1) (28)
0
Capital To ensure net capital spend does not exceed the Welsh
Government Capital Resource Limit. Measured by variance
against plan to manage to the Resource Limit
£’000
+Adverse
()Favourable
(60) (77)
0
Public Sector Payment Policy To pay a minimum of 95% of all Non NHS invoices within 30
days. Measured by actual performance % 95.5 96.0
>95
Finance Report
Month 11
Page 7 of 39 Finance, Performance & Workforce Committee
21 March 2019
3.3 Revenue Performance by Expenditure Category
Annual
Budget
Over/(Under) Spend
Section Current
Month Year to Date Forecast Recurrent Forecast
£'000 £'000 £'000 £'000 £'000
Delegated Budgets
Pay 355,489 518 2,061 2,559 3.5
Non Pay 395,748 936 3,806 3,556 3.6
Income (97,452) (344) 22 370 3.7
Delegated Savings Plans (5,505) (31) 4,975 5,322 3.8
Total Delegated Budgets 648,280 1,079 10,864 11,808
Expected improvement in Delegated
forecast 0 0 0 (923)
See below
Non Delegated Budgets 37,586 (1,080) (10,892) (10,885) 3.9
WG Allocations (685,866) 0 0 0 3.10
GRAND TOTAL M11 0 (1) (28) 0 (4,400)
GRAND TOTAL M10 0 2 (27) 0 (3,500)
Finance Report
Month 11
Page 8 of 39 Finance, Performance & Workforce Committee
21 March 2019
Current Month
The M11 Pay overspend of £518k is a deterioration of £364k compared to the average monthly overspend for the first 10 months of the year of £154k. Significant adverse variances from trend were seen in the following
Directorates: o Acute Medicine £148k ( Medical £83k and Registered Nursing £33k)
o Children & Young People £61k ( Nursing £57k)
The M11 medical agency cost of £1.3m is consistent with the average of the previous 6 months.
The M11 Non pay overspend of £936k represents an deterioration of £649k compared to the average monthly
overspend for the previous 10 months of £287k. The most significant variations from trend were in the following areas:
o Medicines Management - £895k deterioration, mainly growth in primary care prescribing costs (see below) o Mental Health- £270k improvement, mainly Continuing Healthcare
o ACT- £126k improvement, mainly Clinical Supplies
The M11 Income underspend of £344k is an improvement of £381k compared to the average monthly overspend for the first 10 months of the year of £37k. The most significant improvement was in:
o Contracting & Commissioning where the £273k improvement was mainly LTA income with Health Boards (£194k) and Non Contracted Activity (£55k)
o Corporate Functions where the £151k improvement was mainly due to NHS Redress (£135k).
The M11 Delegated savings overachievement of £31k is an improvement of £532k from the M10 monthly trend of £501k. This is mainly due to the improvement in Contracting & Commissioning Savings.
Finance Report
Month 11
Page 9 of 39 Finance, Performance & Workforce Committee
21 March 2019
Year to Date
The M11 YTD Pay overspend of £2.1m includes a medical pay overspend of £3.5m. Medical and dental pay overspends have been steadily increasing in 2018/19 and this remains a key area of concern. A detailed analysis of the Medical
and Dental pay overspends at M10 was discussed at the FP&W Committee in February which included information on individual directorate overspends, key drivers for the over spends and actions being taken to reduce the overspends.
The M11 YTD Non pay over spend is £3.8m. Funding has been set aside for circa £1.3m of this overspend but has yet
to be allocated to directorates. The key overspending areas within the balance of £2.5m include:
o Medicines Mgt £1609k (see below)
o Pathology £432k, mainly drugs o Facilities £291k, mainly catering provisions
o Localities £262k, mainly Continuing Healthcare o Estates £309k, mainly increased energy costs
o PC&S £441k, mainly increased legal claims. The FP&W Committee have requested a report on this area for the March meeting.
The M11 YTD non pay overspend in Medicines Management of £1.6m is attributed to growth in Primary care prescribing
costs exceeding the £3m growth budget for 2018/19. Further work is being undertaken to fully understand the reasons for the increased growth in 2018/19.
The M11 YTD Income over spend is only £0.02m. Overspending areas are identified in Section 3.7
The M11 YTD CRES shortfall on Delegated budgets remains at £5.0m. The combined Savings position (Delegated and Non Delegated) is shown in Section 3.8.
Further information on the M11 YTD Non Delegated under spend is provided in Section 3.9.
The year end forecast has been refreshed, based on Directorates’ delegated budget forecasts based on Month 8 results,
together with updates of non-delegated budget forecasts taking account of the most recent Month 9 information.
Finance Report
Month 11
Page 10 of 39 Finance, Performance & Workforce Committee
21 March 2019
Year to Date
The M6 YTD Pay overspend of £1.9m includes a medical pay overspend of £2.0m. Medical and dental pay overspends have been steadily increasing in 2018/19 and this is a key area of concern. A detailed analysis of the Medical and
Dental pay overspends was provided in the M4 Finance report, which provided information on individual directorate overspends, key drivers for the overspends , actions being taken to reduce the overspends and what impact the
actions are forecast to have if successful. We are planning to refresh this analysis based on M6 data as a separate report to the FP&W Committee in November or December.
The M6 YTD Non pay over spend is now only £0.2m. Overspending areas are identified in Section 3.6.
The M6 YTD Income over spend is only £0.2m. Overspending areas are identified in Section 3.7
The M6 YTD CRES shortfall on Delegated budgets is £3.2m. The trend rate of savings and forecast full year savings are
largely static. The combined Savings position (Delegated and Non Delegated) is shown in Section 3.8.
Further information on the M6 YTD Non Delegated under spend is provided in Section 3.9.
Year End Forecast
The year end forecast has been refreshed, based on Directorates’ delegated budget forecasts based on Month 5 results,
together with updates of non-delegated budget forecasts taking account of the most recent Month 6 information.
Year End Forecast
The following table summarises the latest In Year forecast for 2018/19 and the main changes since M10.
There are several key points to note regarding the In year forecast:
No change to the overall forecast break even position, with the £0.9m deterioration in the bottom up delegated and non delegated forecasts being offset by an expected improvement in the total Year end delegated forecast of £11.8m.
The total Year end delegated forecast of £11.8m includes assumed funding of £1.3m. Without this funding the forecast overspend would increase to £13.1m which represents an increase of £2.2m over and above the M11 YTD overspend of
£10.9m. This is £1.3m above the average monthly overspend to M11 and we are expecting this to improve by circa £0.9m in M12.
The M10 forecast for Medicines Mgt has deteriorated by £1.1m from the M9 forecast. As noted above the main reason
for this deterioration is growth in primary care prescribing costs.
2018/19 In Year
forecast
2018/19
Recurrent
Forecast
£k £k
Month 10 Executive Board ( M9 forecasts) 0 -3500
Month 10 Movements- Delegated forecasts:
Medicines Mgt 1145 1124
Net movement across all otherdirectorates -362 -91
Sub total 783 1033
Expected improvement in Delegated forecast -923 0
Month 10 Movements- Non Delegated forecasts:
Other cost pressures 140 -912Reduction in forecast Delegated overspend linked
to the 2019/20 IMTP submission 0 -1,000
Sub total 140 -1912
Net movement in M11 0 -879
M11 Executive Board ( M10 forecasts) 0 -4379
Planned deficit 4800
Recurring Forecast - 19/20 421
Finance Report
Month 11
Page 11 of 39 Finance, Performance & Workforce Committee
21 March 2019
Revenue Performance by Division The key points to note regarding the Recurrent forecast are as follows:
The 2018/19 Financial Plan had a planned recurrent deficit going into 2019/20 of £4.8m. Following detailed work for the
January IMTP submission to WG, the M10 Finance report showed a forecast recurrent underspend against plan in 2018/19 of £3.5m which reduced the recurrent deficit going into next year to £1.3m. We have recently re-submitted our IMTP to
WG on 7 March and this has further reduced the recurrent deficit going into next year by a further £0.9m to £0.4m.
Finance Report
Month 11
Page 12 of 39 Finance, Performance & Workforce Committee
21 March 2019
3.4 Revenue Performance by Division
Over/(Under) Spend
Annual
Budget Current Month Year to Date Forecast
Recurrent
Forecast
£'000 £'000 £'000 £'000 £'000
Chief Operating Officer:
Unscheduled Care 83,049 411 3,646 3,506
Planned Care 105,542 39 3,209 3,644
Clinical Support 48,776 253 1,404 1,075
Facilities 26,957 99 1,132 1,452
Total COO 264,324 801 9,390 9,676
PCMH:
Primary & Community 145,343 43 1,989 2,404
Mental Health 51,488 (297) (982) (922)
Medicines Management 81,935 854 1,585 1,586
Total PCMH 278,767 600 2,592 3,068
Contracting & Commissioning 54,661 (149) (867) (776)
Corporate Functions 50,528 (173) (251) (160)
Total Delegated Budgets 648,280 1,079 10,864 11,808
Expected improvement in
Delegated forecast 0 0 0 (923)
Non Delegated Budgets 37,586 (1,080) (10,892) (10,885)
WG Allocations (685,866) (0) (0) 0
GRAND TOTAL M11 0 (1) (28) 0 (4,400)
GRAND TOTAL M10 0 2 (27) 0 (3,500)
Finance Report
Month 11
Page 13 of 39 Finance, Performance & Workforce Committee
21 March 2019
Current Month
The above table shows the current month, YTD and forecast positions by Division rather than by Expenditure
categories as in Section 3.3 above.
The main areas of overspends , expressed as a % of budget are as follows: - Medicines Management 12.51%, Clinical Support 6.2%, Unscheduled care 5.9% and Facilities 4.4%
Year to Date
The delegated budget overspend of £10.9m is concentrated in the acute service areas, and particularly
Unscheduled Care and Planned Care. However, the £2.6m overspend in PCMH is also much higher than in previous years. This is largely attributable to Primary care prescribing (£1.6m), CRES shortfalls in Primary,
Children and Community services (£0.7m) and pay overspends in managed practices (£0.4m).
The main areas of overspends , expressed as a % of budget are as follows: - Unscheduled care 4.8%, Planned care 3.4%, Clinical support 3.1% and Facilities 4.7%
- Primary & Community 1.5% and Medicines Management 2.1%
Year End Forecasts
The basis of the in year and recurrent forecasts are described in Section 3.3 above by Expenditure category. The table above shows the same forecast by Division.
Finance Report
Month 11
Page 14 of 39 Finance, Performance & Workforce Committee
21 March 2019
3.5 Pay Expenditure
Monthly Trends (Please note scale of Y-axis)
M11 Agency
Expenditure Total Agency Expenditure
Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar YTD
£’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000
2018/19 Total 1,586 1,640 1,615 1,757 2,006 1,924 1,992 2,144 1,806 2,242 2,280 20,990
% of Total Pay 5.6% 5.6% 5.7% 6.1% 6.9% 6.7% 6.9% 6.3% 5.9% 7.5% 7.5% 6.4%
2017/18 Total 1,964 1,706 1,585 1,958 1,781 2,322 1,484 1,620 1,374 1,932 1,734 1,974 21,433
% of Total Pay 7.0% 5.9% 5.7% 7.0% 6.2% 8.2% 5.3% 5.6% 4.9% 6.9% 6.0% 6.6% 6.3%
25,000
26,000
27,000
28,000
29,000
30,000
31,000
32,000
33,000
34,000
35,000
Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar
Total Pay Expenditure £'000
2017/18 Actual 2018/19 Budget 2018/19 Actual
Key Issues
The November budget was increased by
£4m to reflect the pay award arrears for
Agenda for change staff for April to
September.
The December budget was increased by
£1.1m to reflect the pay award and arrears
for Medical & Dental staff.
Total expenditure in M11 increased by
£0.85m from the average to M10. This is
due to increased agency of £0.4m and
increased substantive costs of £0.3m.
The increased budget for M12 mainly
includes reserves for Mental Health funding
and transition funding for the Bridgend
boundary change.
Finance Report
Month 11
Page 15 of 39 Finance, Performance & Workforce Committee
21 March 2019
Performance by Staff Category
Annual
Budget
Current Month
Variance
Year to
Date
Variance
YTD Variance
as % of YTD
budget
£'000 £'000 £'000 %
Medical And Dental 87,639 405 3,542 4.43%
Wards and A&E Nursing:
Registered Nursing 32,622 4 (49) -0.17%
Additional Clinical Services 18,224 98 1,342 8.06%
Sub-Total Wards & A&E Nursing 50,847 102 1,293 2.78%
Other Nursing:
Registered Nursing 80,061 (132) (2,360) -3.26%
Additional Clinical Services 14,891 50 1,105 8.14%
Sub-Total Other Nursing 94,952 (82) (1,255) -1.46%
Additional Clinical Services 7,834 (64) (63) -0.88%
Allied Health Professionals 20,183 (24) (267) -1.45%
Add Prof Scientific And Technical 13,207 (12) (543) -4.49%
Administrative & Clerical 49,811 75 (948) -2.10%
Estates And Ancillary 20,847 53 318 1.66%
Healthcare Scientists 10,168 63 (26) -0.28%
Other 0 1 10
Grand Total 355,489 518 2,061 0.64%
Key Issues
The vast majority of the 2017/18 pay overspends
were fully funded in the 2018/19 financial plan,
with corresponding savings targets to
reduce expenditure.
The continued
overspends seen in Medical & Dental and
Wards and A&E are therefore a significant
concern. These 2 areas are discussed further
below.
Within Other Nursing, the over spends in
Additional Clinical Services at a directorate
level are mainly offset by
corresponding under spends in Registered
Nursing.
Finance Report
Month 11
Page 16 of 39 Finance, Performance & Workforce Committee
21 March 2019
Performance by Division
In Month Variance Year to Date Variance Over/(Under) Spend Over/(Under) Spend
Annual
Budget
Last
Month
Current
Month Change Current Month
£'000 £'000 £'000 £'000 £'000
Chief Operating Officer:
Unscheduled Care 69,065 (138) 268 406 1,467
Planned Care 87,093 35 7 (28) 1,019
Clinical Support 39,354 (105) 45 150 36
Facilities 20,291 28 36 8 149
Total COO 215,803 (180) 356 536 2,671
PCMH:
Primary & Community 73,896 57 95 38 173
Mental Health 27,647 (3) 11 14 92
Medicines Management 8,053 (13) 12 25 (5)
Total PCMH 109,596 42 118 77 260
Contracting & Commissioning 0 0 0 0 0
Corporate Functions 30,090 (107) 44 151 (870)
GRAND TOTAL 355,489 (246) 518 764 2,061
Key Issues
M11 is reporting a pay overspend of £518k compared to an under spend of £246k in M10. The M11 Pay overspend of £518k is a deterioration of £364k compared to the average monthly overspend for the first 10 months of the year
of £154k.
Significant deteriorations from trend were seen in the following Directorates: o Acute Medicine £148k ( Medical £83k and Registered Nursing £33k)
o Children & Young People £61k ( Registered Nursing £57k)
The M11 YTD overspend of £2,061k is mainly within the Unscheduled Care and Planned Care Divisions.
Finance Report
Month 11
Page 17 of 39 Finance, Performance & Workforce Committee
21 March 2019
Medical and Dental Pay Expenditure
The chart below shows the trends of Medical & Dental pay expenditure and budget. (Please note scale of Y-axis)
£6.0m
£6.5m
£7.0m
£7.5m
£8.0m
£8.5m
£9.0m
Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19
Medical & Dental Pay Expenditure
2017/18 Actual Budget 2018/19 Actual
76%
16%
8%
Current Mth
78%
15%
7%
YTD 2018/19
79%
15%
6%
2017/18
SUBSTANTIVE
AGENCY
LOCUM
Key Issues Expenditure in M11 remained
relatively static at £7.9m.
The M11 YTD variance is £3.5m adverse.
The M11 YTD savings for Medical
Staffing cross cutting theme is only
£1.1m compared to a target of £3.6m (See section 3.8).
The M11 medical agency cost of
£1.26m has slightly decreased compared to last month.
M11 agency expenditure accounted
for 16% of total Medical & Dental pay, compared to 15% year to date
and 15% for 2017/18.
The medical pay position remains a concern with a continuation of
increased expenditure levels.
Finance Report
Month 11
Page 18 of 39 Finance, Performance & Workforce Committee
21 March 2019
The table below shows current monthly medical and dental agency expenditure and provides a comparison to the
previous year.
M11 Medical & Medical & Dental Agency Expenditure
Dental Agency
Expenditure Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar YTD
£’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000
2018/19 Total 941 1,035 930 1,086 1,262 1,256 1,269 1,332 1,058 1,307 1,261 12,738
% of Total Medical &
Dental Pay 13.1% 14.2% 13.2% 14.7% 16.6% 16.6% 17.6% 16.7% 12.5% 16.6% 15.9% 15.2%
2017/18 Total 1,096 1,006 1,073 1,160 1,039 1,369 1,055 1,097 1,028 1,458 1,102 940 13,424
% of Total Medical &
Dental Pay 15.7% 14.3% 15.4% 16.5% 14.5% 18.4% 14.8% 14.7% 14.1% 20.3% 14.5% 11.6% 15.4%
Key Issues
The level of medical and dental pay overspends remains a key area of concern. A detailed analysis of the
Medical and Dental pay overspends at M10 was discussed at the FP&W Committee in February.
Finance Report
Month 11
Page 19 of 39 Finance, Performance & Workforce Committee
21 March 2019
Registered Nursing - Wards and A&E Pay Expenditure
The charts below show the monthly trends for Registered Nursing Wards and A&E pay expenditure & budget. (Please note scale of Y-axis)
£2.0m
£2.2m
£2.4m
£2.6m
£2.8m
£3.0m
£3.2m
Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19
Registered Nursing Pay ExpenditureWards & A&E
2017/18 Actual Budget 2018/19 Actual
80%
19%
1%
Current Mth
82%
17%
1%
YTD 2018/19
84%
15%1%
2017/18
SUBSTANTIVE
AGENCY
BANK
Key Issues The Ward and A&E budgets for
2018/19 were set based on the actual expenditure levels in M8-10 of
2017/18.
The M8 budget was increased by £320k to reflect the pay award
arrears for Agenda for change staff.
Expenditure in M11 is unchanged from M10 at £2.7m.
The M11 YTD Variance is £49k
favourable.
The M11 agency cost has remained
static at £524k. The M11 YTD agency cost now exceeds £5m.
M11 agency expenditure accounted
for 19% of total Ward and A&E registered nursing pay, compared to
17% YTD and 15% for 2017/18.
Finance Report
Month 11
Page 20 of 39 Finance, Performance & Workforce Committee
21 March 2019
Registered Nursing - Wards and A&E Agency Expenditure
The table below shows current monthly Registered Nursing Wards and A&E nursing agency expenditure and provides a comparison to the previous year.
M11 Wards and
A&E Wards and A&E Registered Nursing Agency Expenditure
Registered
Nursing Agency
Expenditure Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar YTD
£’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000
2018/19 Total 398 383 380 406 506 487 514 477 488 523 524 5,087
% of Total Pay 15.3% 14.1% 14.9% 15.6% 18.4% 18.8% 19.2% 15.6% 17.8% 19.1% 19.0% 17.1%
2017/18 Total 556 398 141 503 441 574 226 293 292 266 369 602 4,660
% of Total Pay 20.1% 14.2% 5.8% 18.4% 16.1% 21.0% 9.3% 11.4% 11.9% 11.0% 13.9% 21.4% 14.8%
Finance Report
Month 11
Page 21 of 39 Finance, Performance & Workforce Committee
21 March 2019
Additional Clinical Services – Wards and A&E Pay Expenditure
The chart below show the monthly trends for Additional Clinical Services Wards and A&E pay expenditure & budget. (Please note scale of Y-axis)
£1.0m
£1.1m
£1.2m
£1.3m
£1.4m
£1.5m
£1.6m
£1.7m
£1.8m
Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19
Add Clinical Services Pay ExpenditureWards & A&E
2017/18 Actual Budget 2018/19 Actual
72%
0%
28%
Current Mth
71%
1%
28%
YTD 2018/19
71%
0%
29%
2017/18
SUBSTANTIVE
AGENCY
BANK
Key Issues
The M8 budget was increased by
£240k to reflect the pay award
arrears for Agenda for change staff.
Expenditure in M11 is unchanged from M10 at £1.6m
The M11 YTD variance is £1,342k
adverse.
The M11 YTD total variance for Wards and A&E (Registered and
Additional Clinical Services) is therefore £1,293k adverse.
As at M11 only £74k of savings have
been reported for the Ward and A&E
Nursing Theme against a target of £1.8m (see section 3.8).
Finance Report
Month 11
Page 22 of 39 Finance, Performance & Workforce Committee
21 March 2019
3.6 Non Pay Expenditure
Monthly Trends
The chart below shows the monthly trends of non pay expenditure and budgets: (Please note scale of Y-axis)
£20.0m
£25.0m
£30.0m
£35.0m
£40.0m
£45.0m
£50.0m
£55.0m
Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar
Total Non Pay Expenditure £'000
2017/18 Actual Budget 2018/19 Actual
Key Issues Expenditure in M11 decreased by
£1.7m from M10. The decrease was mainly CHC/FNC £0.9m, Primary Care
Prescribing £0.4m and WHSSC/EASC £0.7m
The M11 YTD variance is now £3.8m
adverse.
The increased budget for M12 mainly
includes directorate based reserves for:
NICE/High cost drugs (£1.5m) Nursing Home Pooled Budget
(£12.0m) Imaging Academy (£0.9m)
Partnerships (£0.9m) Facilities (£0.8m)
Estates (£0.3m)
Finance Report
Month 11
Page 23 of 39 Finance, Performance & Workforce Committee
21 March 2019
Performance by Expenditure Category
The table below details in month and year to date variances in respect of non-pay expenditure.
Annual
Budget
Current
Month
Variance
Year to
Date
Variance
YTD Variance
as % of YTD
budget
£'000 £'000 £'000 %
Primary Care & Contracts
Primary Care Contracts 78,835 (4) (70) (0.10%)
Primary Care Prescribing 53,555 934 1,580 3.25%
CHC & FNC 48,264 (309) (482) (1.45%)
Secondary Healthcare 4,259 38 35 0.90%
Purchases of Healthcare
Services 3,784 (1) 19 0.83%
Services from Other NHS Bodies 112,187 (112) (507) (0.49%)
Total Primary Care & Contracts
300,885 546 575 0.22%
Traditional Non Pay
Secondary Care Drugs 28,693 (37) 889 3.28%
Clinical Supplies & Services 25,136 61 453 1.99%
General Supplies & Services 3,990 7 475 12.93%
Establishment Expenses 9,137 53 504 6.03%
Contract Staffing & Consultancy 138 9 119 95.34%
Misc Services - Other 11,516 172 146 2.27%
Premises & Fixed Plant 16,254 126 645 4.39%
Total Traditional Non Pay 94,863 390 3,230 3.88%
GRAND TOTAL 395,748 936 3,806 1.10%
Key Issues:
The M11 Non Pay overspend of
£937k represents a deterioration compared to the average monthly
overspend for the first 10 months
of the year of £287k.
The most significant areas of deterioration in trend were in the
following areas: - Primary Care Prescribing £870k
The most significant areas of
improvement in trend were in the following areas:
- CHC £292k - Secondary Care Drugs £130k
Further information on the YTD
overspending areas is provided
overleaf.
Finance Report
Month 11
Page 24 of 39 Finance, Performance & Workforce Committee
21 March 2019
The table below provides an analysis of the most significant year to date non-pay overspends noted above:
Analysis of significant Non-Pay Year to Date Over Spends
Variance
£’000
Pathology 345
Acute Medicine 268
ACT 93
Other 183
Total - Secondary Care Drugs 889
Utilities 377
Furniture & fittings 228
Photocopying rental & charges 33
Primary Care – Premises Contracts 60
Other (53)
Total – Premises & Fixed Plant 645
Catering Provisions 349
Housekeeping 122
Other 4
Total – General Supplies & Services 475
Stationery 131
Training 116
Advertising 146
Legal Fees 107
Other 4
Total – Establishment Expenses 504
Medical & Surgical Equipment 486
Dressings (176)
Reporting 85
Other 53
Total – Clinical Supplies & Services 453
Key Issues
The drug overspends in Pathology and Acute Medicine continue to
increase. Further work is being undertaken to understand the
reasons for these overspends and this will inform budget setting for
19/20.
The premises & Fixed Plant over spend is mainly attributed to
Estates £293k, Acute Medicine
£149k and Pathology £58k.
The over spend in General supplies and services is almost wholly
attribute to Facilities.
The most significant overspend in Establishment expenses are within
CAMHS, Primary Care, Workforce & OD and Mental Health.
The clinical supplies and services
overspend is mainly attributed to Acute Medicine £187k, ACT £190k
and Radiology £209k.
Finance Report
Month 11
Page 25 of 39 Finance, Performance & Workforce Committee
21 March 2019
Primary Care Prescribing
Continuing Healthcare (CHC)
£3.0m
£3.5m
£4.0m
£4.5m
£5.0m
£5.5m
Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar
Primary Care Prescribing Expenditure £'m
2017/18 Actual Budget 2018/19 Actual
£0.0m
£0.5m
£1.0m
£1.5m
£2.0m
£2.5m
£3.0m
£3.5m
Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar
Continuing Healthcare Expenditure £'m
2017/18 Actual Budget 2018/19 Actual
Key Issues
o The production of primary care prescribing
data is usually 2 months following the month end. As such M10 & M11 are therefore
estimated costs rather than actual. o The M11 YTD position is reporting an over
spend of £1,580k. This is after M11 YTD savings of £1,500k. The over spend is
attributed to growth in Primary care prescribing costs exceeding the £3m growth
budget.
o
Key Issues
o The increase in both budget and expenditure in M8 reflects agreement on new rates for
nursing homes for 2018/19.
o The M11 YTD position is reporting an under spend of £423k. This is after M11 YTD
savings of £874k.
Finance Report
Month 11
Page 26 of 39 Finance, Performance & Workforce Committee
21 March 2019
Performance by Division
Annual Budget
In Month Year to Date
Over/(Under) Spend Over/(Under) Spend
Last Month Current Month Change Current Month
£'000 £'000 £'000 £'000 £'000
Chief Operating Officer:
Unscheduled Care 16,032 15 61 46 706
Planned Care 22,379 0 (142) (142) 241
Clinical Support 12,427 163 152 (11) 838
Facilities 10,820 112 16 (96) 291
Total COO 61,658 290 87 (203) 2,076
PCMH:
Primary & Community 96,077 259 14 (245) 448
Mental Health 25,382 133 (290) (423) (487)
Medicines Management 77,926 180 960 780 1,609
Total PCMH 199,385 572 685 113 1,571
Contracting & Commissioning 108,566 (684) 191 875 (729)
Corporate Functions 26,139 65 (27) (92) 888
GRAND TOTAL 395,748 242 936 693 3,806
Key Issues: The M11 overspend of £936k represents a deterioration of £693k from the £242k overspend in M10 and a
£649k deterioration compared to the average monthly overspend for the previous 10 months.
The most significant deterioration in M11 was seen in Medicines Management where the deterioration from trend of £895k was due to additional costs in relation to primary care prescribing. This significant change is
a retrospective correction of growth assumptions relating to previous months and is not solely a M11 issue.
The M11 YTD overspend of £3.8m includes £1.6m in relation to Medicines Management/primary care prescribing.
Finance Report
Month 11
Page 27 of 39 Finance, Performance & Workforce Committee
21 March 2019
3.7 Income
Performance by Income Category
Annual
Budget
Current
Month
Variance
Year to
Date
Variance
YTD
Variance as
% of YTD
budget
£'000 £'000 £'000 %
Income From Activities
Dental Income (3,900) (2) (92) (2.58%)
Local Health Boards (39,798) (126) (50) (0.14%)
Other (34,412) (183) 71 0.33%
Total Income from Activities (78,109) (311) (71) (0.12%)
Other Operating Income
Accommodation & Catering (2,512) (6) (99) (4.36%)
Charitable & Other Contributions (464) 12 33 7.52%
Education & Training (10,287) (22) (51) (0.54%)
Laundry, Pathology & Payroll (499) 8 (60) (12.62%)
Mortuary Fees (277) 1 (2) (0.67%)
Non Patient Care – Income Generation
(552) (8) 39 7.62%
Other Income (4,499) (24) 184 4.42%
Staff Payments for use of Cars (251) 7 48 21.44%
Total Other Operating Income (19,343) (31) 93 0.52%
GRAND TOTAL (97,452) (342) 22 0.03%
Key Issues
The most significant adverse YTD variances
relate to: WHSSC LTA Income
£312k, mainly due to reduced NICU activity
Injury Cost recovery Scheme £285k
Primary Care Support Unit Income £284k
The most significant
Favourable YTD variances relate to:
NHS Trusts £295k
Local Authorities £133k Medicines Rebates
£111k Accommodation &
Catering £99k Dental Income £92k
Finance Report
Month 11
Page 28 of 39 Finance, Performance & Workforce Committee
21 March 2019
Performance by Division
Annual
Budget
In Month Year to Date
Over/(Under) Spend Over/(Under)
Spend
Last Month Current Month Change Current Month
£'000 £'000 £'000 £'000 £'000
Chief Operating Officer:
Unscheduled Care (368) (6) (16) (10) 27
Planned Care (1,977) 12 13 1 158
Clinical Support (2,198) 1 12 11 (166)
Facilities (3,369) (4) (13) (9) (31)
Total COO (7,913) 3 (4) (7) (12)
PCMH:
Primary Care, Children & Community (23,782) (85) (109) (24) 622
Mental Health (1,500) (97) (61) 36 (531)
Medicines Management (4,044) (5) 11 16 (84)
Total PCMH (29,326) (187) (159) 28 7
Contracting & Commissioning (54,393) 259 (14) (273) 188
Corporate Functions (5,820) (15) (166) (151) (161)
GRAND TOTAL (97,452) 61 (343) (403) 22
Key Issues
The M11 underspend of £343k represents an improvement of £403k from the £61k overspend in M10 and a £380k improvement compared to the average monthly overspend for the previous 10 months.
There were no significant areas of deterioration in M11.
The most significant improvement was in Contracting & Commissioning where the £273k improvement was mainly LTA income with Health Boards (£194k) and Non Contracted Activity (£55k).
There was also a £151k improvement in Corporate Functions which was mainly due to NHS Redress income of £135k.
The M11 YTD position is a £22k overspend.
Finance Report
Month 11
Page 29 of 39 Finance, Performance & Workforce Committee
21 March 2019
3.8 Savings Plan Performance
Annual Plan
Variance Against Plan
Current
Month Year to Date Forecast Recurrent Forecast
£'000 £'000 £'000 £'000 £'000
Chief Operating Officer:
Unscheduled Care 3,038 97 1,446 1,512
Planned Care 2,931 161 1,791 1,956
Clinical Support 1,364 44 695 663
Facilities 1,177 59 723 759
Total COO 8,510 361 4,655 4,891
PCMH:
Primary & Community 1,683 43 745 669
Mental Health 1,751 42 (57) 0
Medicines Management 1,910 (129) 65 0
Total PCMH 5,344 (43) 754 670
Contracting & Commissioning 500 (325) (325) (117)
Corporate Functions 732 (24) (109) (121)
Total Delegated Budgets 15,087 (31) 4,975 5,322
Non Delegated Savings Plans 200 (211) (1,447) (1,660)
CCT to be allocated to Directorates – Planned Care. 1,000 84 917 1,000
CCT to be allocated to Directorates – Unscheduled Care. 1,000 84 917 1,000
CCT to be allocated to Directorates – Value Based HC. 500 41 458 500
Slippage v recurring savings targets (4,162) (347) (3,815) (4,162)
Total Non Delegated Budgets (1,462) (350) (2,971) (3,322)
GRAND TOTAL M11 13,625 (381) 2,004 2,000 2,343
GRAND TOTAL M10 13,625 (299) 2,385 2,754 2,419
Key Issues
The M11 favourable variance of £381k is an improvement of £619k compared to the average monthly overspend for the first 10 months of the year of £238k. This is mainly due to increased savings from Contracting & Commissioning.
Finance Report
Month 11
Page 30 of 39 Finance, Performance & Workforce Committee
21 March 2019
£0.0m
£2.0m
£4.0m
£6.0m
£8.0m
£10.0m
£12.0m
£14.0m
£16.0m
Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar
Saving Plans
Cumm Plan Cumm Actual
Key Issues
M11 YTD savings achievement is £10.5m
against a target of £12.5m, giving an adverse variance of £2.0m.
The latest forecasts are showing total risk
adjusted savings of £11.6m against a target of £13.6m, giving an adverse
variance of £2.0m.
Finance Report
Month 11
Page 31 of 39 Finance, Performance & Workforce Committee
21 March 2019
Year to Date Performance – Savings Achieved
Annual
Target
Savings Achieved
Current Month
Year to Date
Forecast Recurrent Forecast
£'000 £'000 £'000 £'000 £'000
Medical Staffing 3,604 90 1,120 1,198 1,737
Wards & A&E 1,778 0 73 117 135
Other Nursing 1,479 335 943 1,082 611
Non Pay 750 123 1,046 1,242 1,023
Planned Care 1,000 7 43 50 70
Unscheduled Care 1,000 0 0 0 0
Value Based Healthcare 500 0 0 0 0
Directorate Specific 7,451 732 5,628 6,051 5,981
Non Delegated Savings 200 229 1,632 1,860 1,700
Savings Contingency (4,162) 0 0 0 0
Grand Total M11 13,600 1,516 10,485 11,600 11,257
Grand Total M10 13,600 1,434 8,969 10,846 11,181
Key Issues Actual savings to M11 are £10.5m.
Forecast savings are £11.6m compared to a straight line extrapolation of M11 of £11.4m. The annual savings targets for Planned Care, Unscheduled care and Value Based Healthcare themes of £2.5m have
not been allocated to the Directorates.
Finance Report
Month 11
Page 32 of 39 Finance, Performance & Workforce Committee
21 March 2019
3.9 Non Delegated Budgets
Non Delegated Budgets and Reserves M10 Original
Plan
Revised
Plan
Current
Budget
Year to
Date
Variance
Forecast
In Year
Variance
Forecast
Recurrent
Variance
Note
£’000 £’000 £’000 £’000 £’000 £’000
Income and Allocations
Non-recurring Income Target (4,000) (5,000) (5,000) 4,583 5,000
Non-recurring Income Achieved (4,951) (5,401)
Repayment of Prior Year AME funding for CHC provisions 0 0 0 (1,100) (1,200) A
Savings
Recurrent Savings Target (200) (200) (200) 183 200 Section 3.8 Recurrent Savings to be Allocated 0 0 (2,501) 2,293 2,500 Section 3.8 Savings Achievement 1,860 (1,632) (1,860) Section 3.8 Expenditure Budgets
Capital Charges 15,449 15,449 24,977 0 0
Other Budgets 1,979 1,979 3,783 (127) (200)
Reserves and Contingencies
General Contingency 2,700 2,700 2,700 (2,475) (2,700) B
Savings Contingency against Recurrent Savings Targets 3,608 3,608 4,162 (3,815) (4,162) Section
3.8
Earmarked Budgets yet to be Allocated to
Directorates
Service Improvement - Local 2,500 1,500 317 (292) (318)
Service Improvement - Referral to Treatment 3,500 2,000 32 0 0
Service Improvement - WG Earmarked 800 800 0 0 0
Slippage (800) (800) (800) 733 800
Service & Demand Pressures 9,850 7,850 556 1,543 1,683 C
Inflation 9,650 9,650 2,050 (1,758) (1,918) D
Underlying Deficit - Non Pay Overspends 2017/18 3,466 3,466 1,260 (974) 76 E
Prior Year Commitments 5,018 5,018 3,401 (3,103) (3,385) F
Allocations to be yet released 85 85 988 0 0
Reduction in Forecast Delegated overspend linked to
2019/20 IMTP submission 0 0 0 0 0
TOTAL 53,605 48,105 37,585 (10,892) (10,885) (23,855) Notes follow on next page
Finance Report
Month 11
Page 33 of 39 Finance, Performance & Workforce Committee
21 March 2019
Note A - Repayment of Prior Year AME funding for CHC provisions
The IMTP identified a cost pressure from settling retrospective CHC cases that were provided for in 2017/18 and covered by AME funding from WG. As these cases settle, the amounts paid to claimants need to be repaid to WG. Our Financial plan
includes a £1.3m non recurring budget for the anticipated settlement of cases in 2018/19. As at Month 11, only £171k of settlements have been made and we have revised our forecast down to £0.3m, giving rise to a forecast non-recurring under
spend of £1m. The forecast underspend of £1.2m also includes £0.2m in relation to other CHC provisions.
Note B - Uncommitted Reserves and Contingencies
The general contingency of £2.7m and the savings contingency of £4.2m are both being released on a straight line basis.
Note C - Service & Demand Pressures
The revised financial plan for 2018/19 includes £7.9m for service and demand pressures. £7.3m of funding has been allocated to directorates for agreed cost pressures leaving a M11 balance of £0.56m. As at M11 we are forecasting an over
spend of £1,683k, which includes a total sum available for one off investment opportunities in 2018/19 of £4.3m.
Note D - Inflation
The financial plan for 2018/19 included £9.65m for inflation and incremental drift. Further pay award funding of £6.3m has
recently been received WG and £9.3m of pay inflation issued to directorates at M11. Approved final funding has been allocated to directorates for Pay and non pay inflation. As at M11 we are forecasting an under spend of £1.9m.
Note E - Recurring Non Pay Overspends from 2017/18
All directorates have been funded for their forecast recurrent pay overspends from 2017/18. A £1.2m budget is still held in
Reserves for the forecast recurrent non pay overspends from 2017/18. Until allocated out to directorates this reserve balance is being released on a straight line basis to balance any non pay overspends in delegated budgets.
Finance Report
Month 11
Page 34 of 39 Finance, Performance & Workforce Committee
21 March 2019
Note F - Prior Year Commitments
A £3.4m budget is held in Reserves for a range of commitments already made in 2017/18. A number of strategic cross Health Board initiatives, for which the timing of implementation is uncertain, have now been withdrawn. This includes budgets for
the reconfiguration of ENT and Vascular surgery and investment in WCCIS and SARC. This was done to get back as close as possible to the planned recurrent deficit of £4.8m. As and when these changes are proposed for implementation, they will
now need to be prioritised within the 2019/20 financial plan. Our M11 forecast is a £3.4m under spend in 18/19 of which £3.3m is recurrent.
3.10 Welsh Government Allocations
The table below shows the Health Board’s current Welsh Government allocation position:
Annual
Budget
Healthcare & Hospital
Services
Community
Pharmacy Dental
General Medical
Services £'000 £'000 £'000 £'000 £'000
Confirmed Allocations 686,729 604,752 18,680 13,476 49,821
Unconfirmed Allocations (863) (863) 0 0 0
TOTAL 685,866 603,889 18,680 13,476 49,821
Key Issues
The main unconfirmed allocations include:
o Donated Asset Reduction of £(3.2)m, o Transitional funding for the Bridgend boundary change of £1.7m
o WG New Trainees Funding £0.2m
Finance Report
Month 11
Page 35 of 39 Finance, Performance & Workforce Committee
21 March 2019
3.11 Performance against Capital Resource Limit
The actual cumulative capital spend and forecast cumulative capital spend is detailed in the graph below:
0
5,000
10,000
15,000
20,000
25,000
30,000
Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19
Forecast Cumulative Spend £'000 Actual Cumulative Spend £'000
Key Issues
The current Capital Resource Limit
of £23.8m was issued on 5th March 2019.
This is supplemented by an
anticipated £3.2m donated funds, giving an overall programme of
£27.0m.
Expenditure to date is £15.3m
The forecast capital position is
break-even.
Finance Report
Month 11
Page 36 of 39 Finance, Performance & Workforce Committee
21 March 2019
3.12 Public Sector Payment Performance
The Health Board’s monthly performance against the 95% public sector payment target is detailed in the graph below:
93.0%
93.5%
94.0%
94.5%
95.0%
95.5%
96.0%
96.5%
97.0%
97.5%
30 Day Public Sector Payment Policy
Actual Mth Actual YTD Target
Key Issues:
In M11, 95.5% of the number of non
NHS invoices were paid within 30 days.
The forecast position is to achieve
the 95% target for the year.
Finance Report
Month 11
Page 37 of 39 Finance, Performance & Workforce Committee
21 March 2019
3.13 Balance Sheet
The M11 balance sheet is detailed below. Balance Sheet Opening Balance Closing Balance Forecast Closing
(01/04/2018) as at M10 Balance M12
£’000 £’000 £’000
Non Current Assets
Property, Plant & Equipment 362,968 355,933 362,968
Intangible Assets 1,061 1,061 1,061
Trade and Other Receivables 48,087 48,087 48,087
Total Non-Current Assets 412,116 405,081 412,116
Current Assets
Inventories 4,372 4,345 4,372
Trade and Other Receivables 57,355 79,950 57,066
Cash and Cash Equivalents (289) 1,298 172
Total Current Assets 61,438 85,593 61,610
Current Liabilities
Trade and Other Payables 75,689 92,790 75,885
Provisions 34,733 43,504 33,579
Total Current Liabilities 110,422 136,294 109,464
Non-Current Liabilities
Trade and Other Payables 1,621 1,621 1,621
Provisions 53,833 53,833 53,833
Total Non-Current Liabilities 55,454 55,454 55,454
TOTAL ASSETS EMPLOYED 307,678 298,926 308,808
Financed By:
General Fund 276,961 268,209 278,091
Revaluation Reserve 30,717 30,717 30,717
TOTAL 307,678 298,926 308,808
Key Issues
No issues to raise this
month.
Finance Report
Month 11
Page 38 of 39 Finance, Performance & Workforce Committee
21 March 2019
3.14 Cash Flow
A cash flow forecast is detailed in the table below:
Cashflow Forecast Actual/Forecast
Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Total
£’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000
Receipts
WG Revenue Funding 50,374 49,094 64,627 42,372 68,372 47,804 53,105 61,043 55,293 53,748 56,146 65,484 667,461
WG Capital Funding 1,000 2,000 1,500 0 0 2,862 0 900 400 945 1,800 12,421 23,828
Sale of Assets 0 0 1 0 5 0 0 9 48 0 (20) 0 43
Welsh NHS Org'ns 5,978 6,119 4,750 6,280 4,427 5,949 4,920 5,426 4,909 5,253 5,043 5,860 64,914
Other 2,347 2,362 1,532 1,174 2,464 3,379 1,973 2,687 3,277 1,398 4,632 1,722 28,946
Total Receipts 59,699 59,575 72,410 49,826 75,268 59,994 59,998 70,065 63,927 61,344 67,601 85,487 785,193
Payments
Primary Care Services 9,637 9,890 18,049 4,309 16,359 4,862 9,902 16,026 11,510 5,302 10,062 11,124 127,032
Salaries and Wages 23,233 28,028 27,890 27,264 27,763 27,805 27,774 30,409 30,806 28,974 28,481 33,500 341,927
Non Pay Expenditure 20,419 23,900 23,846 20,185 30,003 21,719 23,809 24,232 20,253 24,383 26,807 29,210 288,767
Capital Payments 1,847 854 372 448 766 1,204 1,040 962 868 1,297 2,083 12,151 23,892
Other (Donated asset funding) 244 103 182 159 255 241 239 280 336 447 629 3,114
Total Payments 55,136 62,915 70,260 52,388 75,050 55,845 62,766 71,868 63,717 60,292 67,880 86,614 784,731
Net Cash In/Out 4,562 (3,341) 2,150 (2,562) 218 4,149 (2,768) (1,803) 210 1,052 (279) (1,127)
Balance B/F (289) 4,273 932 3,082 520 738 4,887 2,119 316 526 1,578 1,299
Balance C/F 4,273 932 3,082 520 738 4,887 2,119 316 526 1,578 1,299 172
Key Issues
As at the 28 February 2019 the cash balance was £1.3m. The forecast cash position is break-even.
Finance Report
Month 11
Page 39 of 39 Executive Board Meeting
20 March 2019
4 RECOMMENDATION
The Finance, Performance & Workforce Committee is asked to:
DISCUSS the contents of the Month 11 Finance report for
2018/19.
Freedom of
Information Status
Open